CN117305267A - 葡萄类受体蛋白激酶herk1的新用途 - Google Patents
葡萄类受体蛋白激酶herk1的新用途 Download PDFInfo
- Publication number
- CN117305267A CN117305267A CN202311000390.8A CN202311000390A CN117305267A CN 117305267 A CN117305267 A CN 117305267A CN 202311000390 A CN202311000390 A CN 202311000390A CN 117305267 A CN117305267 A CN 117305267A
- Authority
- CN
- China
- Prior art keywords
- grape
- glrav
- protein kinase
- herk1
- receptor protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014787 Vitis vinifera Nutrition 0.000 title claims abstract description 57
- 235000009754 Vitis X bourquina Nutrition 0.000 title claims abstract description 53
- 235000012333 Vitis X labruscana Nutrition 0.000 title claims abstract description 53
- 102000001253 Protein Kinase Human genes 0.000 title claims abstract description 25
- 108060006633 protein kinase Proteins 0.000 title claims abstract description 25
- 108020003175 receptors Proteins 0.000 title claims abstract description 24
- 102000005962 receptors Human genes 0.000 title claims abstract description 24
- 101100506661 Arabidopsis thaliana HERK1 gene Proteins 0.000 title claims abstract description 21
- 240000006365 Vitis vinifera Species 0.000 title description 5
- 241000219095 Vitis Species 0.000 claims abstract description 54
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 37
- 241000700605 Viruses Species 0.000 claims abstract description 15
- 230000010076 replication Effects 0.000 claims abstract description 15
- 239000013604 expression vector Substances 0.000 claims abstract description 8
- 238000003259 recombinant expression Methods 0.000 claims abstract description 7
- 239000013598 vector Substances 0.000 claims description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 244000141359 Malus pumila Species 0.000 claims description 2
- 101150102092 ccdB gene Proteins 0.000 claims description 2
- 241000905450 Grapevine leafroll-associated virus 2 Species 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 14
- 239000013612 plasmid Substances 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 11
- 241000589158 Agrobacterium Species 0.000 abstract description 9
- 230000002018 overexpression Effects 0.000 abstract description 9
- 206010020649 Hyperkeratosis Diseases 0.000 abstract description 8
- 239000002299 complementary DNA Substances 0.000 abstract description 6
- 241001641949 Desmia funeralis Species 0.000 abstract description 5
- 230000001404 mediated effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 241000219094 Vitaceae Species 0.000 abstract description 2
- 235000021021 grapes Nutrition 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000019491 signal transduction Effects 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241001518863 Grapevine leafroll-associated virus Species 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 102000043136 MAP kinase family Human genes 0.000 description 3
- 108091054455 MAP kinase family Proteins 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101150066478 BAM1 gene Proteins 0.000 description 2
- 102100032305 Bcl-2 homologous antagonist/killer Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 101000798320 Homo sapiens Bcl-2 homologous antagonist/killer Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000005860 defense response to virus Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000008659 phytopathology Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 description 1
- 241000883990 Flabellum Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 101150040099 MAP2K2 gene Proteins 0.000 description 1
- 101150049628 MPK4 gene Proteins 0.000 description 1
- 101150028463 NIK1 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100022239 Peroxiredoxin-6 Human genes 0.000 description 1
- 101800001016 Picornain 3C-like protease Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000891 luminescent agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 101150068383 mkk2 gene Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及一种葡萄类受体蛋白激酶的新用途。本发明所述的葡萄类受体蛋白激酶HERK1(VvHERK1)、编码该VvHERK1的编码基因、含有前述编码基因的重组表达载体可以抑制葡萄卷叶伴随病毒2号(GLRaV‑2)基因组的复制。本发明分别通过在葡萄愈伤组织和组培苗中用农杆菌介导法共转化能表达葡萄类受体蛋白激酶HERK1(VvHERK1)的质粒和GLRaV‑2侵染性cDNA克隆，发现过表达VvHERK1可将GLRaV‑2的RNA和蛋白水平均降低约50％，这表明过表达VvHERK1可极有效抑制GLRaV‑2基因组复制，可以有效防治葡萄卷叶病，同时有利于葡萄的分子育种。
Description
技术领域
本发明涉及植物基因工程技术领域，具体说是一种葡萄类受体蛋白激酶HERK1的新用途
背景技术
葡萄是我国重要的栽培物种，据统计，2019年我国葡萄种植面积高达1062万亩左右。而葡萄也是感染病毒最多的果树树种之一，在生产中发生严重的葡萄病毒病主要有葡萄卷叶病、扇叶病和栓皮综合症，其中葡萄卷叶病是世界范围内发生最普遍、危害最严重的葡萄病毒病害(Naidu R A，Maree H J，Burger J T.Grapevine leafroll disease andassociated viruses：a unique pathosystem.Annual Review of Phytopathology，2015，53：613-634)，在我国的发生率更是高达80-90％(Liu M H，Li MJ，Qi H H，etal.Occurrence of grapevine leafroll-associated viruses in China.PlantDisease，2013，97：1339-1345)。该病可造成葡萄产量减少30-40％左右，葡萄果粒大小不等、着色差、且可溶性固形物含量显著降低，严重影响葡萄产量和品质(Song Y，Hanner RH，Meng B.Probing into the effects of grapevine leafroll-associated viruses onthe physiology，fruit quality and gene expression of grapes.Viruses，2021，13：593)。目前，葡萄卷叶病已成为制约我国葡萄产业发展的关键因素。已知有6种葡萄卷叶伴随病毒(GLRaVs)与该病相关，而葡萄卷叶伴随病毒2号(GLRaV-2)是与葡萄卷叶病相关最重要的病原物之一(Song Y，Hanner R H，Meng B.Probing into the effects of grapevineleafroll-associated viruses on the physiology，fruit quality and geneexpression of grapes.Viruses，2021，13：593)。此外，GLRaV-2侵染也与葡萄嫁接不亲和综合症的发生有关(Meng B，Martelli GP，Golino DA，et al.Grapevine Viruses：Molecular Biology，Diagnostics and Management||Grapevine leafroll-associatedvirus 2.2017，10.1007/978-3-319-57706-7：141-165)。与其它植物病毒病害一样，葡萄植株一旦被GLRaVs等病毒入侵，则难以用化学药剂防治。因此鉴定葡萄植物在抗GLRaVs防卫反应中起重要作用的蛋白，可拓宽对葡萄卷叶病的防控途径，并为最终通过转基因技术获得抗GLRaVs葡萄新种质提供重要的理论依据和试验材料。
在病毒入侵时，植物会采取多种防御途径如促分裂原活化激酶(mitogen-activated protein kinase，MAPK)级联信号途径(Hu T，Huang C，HeY，et al.βC1 proteinencoded in geminivirus satellite concertedly targets MKK2 and MPK4 to counterhost defense.PLoS Pathogen，2019，15：e1007728)及SA、JA等介导的信号传导途径(Alazem M，Lin N S.Roles of plant hormones in the regulation of host virrusinteractions.Molecular Plant Pathology，2015，16：529-540)来抵抗病毒侵染。目前已知植物类受体蛋白激酶(receptor-like kinase，RLK)在其中起着极其关键的作用(Antolin-overa M，Ried M，Binder A，et al.Receptor kinase signaling pathways inplant-microbe interactions.Annual Review of Phytopathology，2012，50：451-473)。
RLK是一类跨膜蛋白激酶家族，是蛋白激酶中的重要一类，也是信号分子的重要受体，能够感受外界刺激，从而在信号转导过程中起着重要作用。植物遭受病原物入侵时，RLK的胞外结构域识别细胞外的病原信号分子后将信号传递到胞内，其胞内激酶结构域随后通过磷酸化将信号传导到下游蛋白，从而启动一系列下游信号转导途径，如MAPK、SA、JA等信号通路，最终诱导植物抗病防卫基因如病程相关蛋白基因、防御素基因等的表达。目前已发现有几种RLKs如BAK1、BAM1和NIK1在植物抗病毒防卫反应起十分重要的作用。如植物在遭受病毒入侵时可以通过BAK1激发植物病原相关分子模式(PTI)防御机制(C J，Klauser D，Niehl A，et al.The immunity regulator BAK1 contributes to resistanceagainst diverse RNA viruses.Molecular Plant-Microbe Interaction，2013，26：1271-1280)。BAM1通过促进RNA沉默信号在细胞间移动而在植物抗病毒防卫反应中起重要作用(Rosas-Diaz T，Zhang D，Fan P，et al.A virus-targeted plant receptor-like kinasepromotes cell-to-cell spread of RNAi.PNAS.2018，115：1388-1393)。此外，NKI1也介导植物抗病毒信号途径(Carvalho C，Santos A，Pires S，et al.Regulated nucleartrafficking of rpL10Amediated by NIK1represents a defense strategy of plantcells against viruses.PLoS Pathogen，2008，4：e1000247)。但目前尚不清楚其它众多RLK家族成员在病毒侵染时的功能。
发明内容
针对现有技术中存在的缺陷，本发明的目的在于提供一种葡萄类受体蛋白激酶HERK1的新用途。本发明分别通过在葡萄愈伤组织和组培苗中用农杆菌介导法共转化能表达葡萄类受体蛋白激酶HERK1(VvHERK1)的质粒和GLRaV-2侵染性cDNA克隆，发现过表达VvHERK1可极有效抑制GLRaV-2基因组复制，有利于防治葡萄卷叶病和葡萄的分子育种。
为达到以上目的，本发明采取的技术方案是：
葡萄类受体蛋白激酶HERK1(VvHERK1)的新用途，其特征在于，所述葡萄类受体蛋白激酶HERK1可以抑制GLRaV-2基因组的复制，上述葡萄类受体蛋白激酶HERK1的序列如SEQID NO：1所示。
编码上述葡萄类受体蛋白激酶HERK1的编码基因的应用，其特征在于：所述编码基因通过其编码的葡萄类受体蛋白激酶HERK1可以抑制GLRaV-2基因组的复制，上述编码基因的序列如SEQ ID NO：2所示。
含有上述编码基因的重组表达载体的应用，其特征在于：所述重组表达载体上包含的编码基因通过其编码的葡萄类受体蛋白激酶HERK1可以抑制苹果茎沟病毒基因组的复制；
所述重组载体为在pK2GW7载体将ccdB序列替换为SEQ ID NO：2所示序列得到的重组表达载体。
本发明所述的葡萄类受体蛋白激酶HERK1的新用途，其有益效果为：
通过在葡萄愈伤组织和组培苗中用农杆菌介导法共转化能表达葡萄类受体蛋白激酶HERK1(VvHERK1)的质粒和GLRaV-2侵染性cDNA克隆，发现过表达VvHERK1可将GLRaV-2的RNA和蛋白水平均降低约50％，表明过表达VvHERK1可极有效抑制GLRaV-2基因组复制。这将在防治葡萄卷叶病中发挥重要作用，同时为葡萄的分子育种打下良好的基础。
附图说明
本发明有如下附图：
图1为pK2GW7-VvHERK1重组载体示意图；
图2为菌落PCR筛选pK2GW7-VvHERK1重组载体；
图3为在葡萄愈伤组织中过表达VvHERK1对GLRaV-2基因组复制的影响；
图4为在葡萄组培苗中过表达VvHERK1对GLRaV-2基因组复制的影响。
具体实施方式
以下结合附图对本发明作进一步详细说明。
下述实施例中所用的材料、试剂等，如无特殊说明，均可从商业途径得到。
实施案例1、过表达葡萄类受体蛋白激酶VvHERK1抑制葡萄卷叶伴随病毒2号基因组复制。
一、构建VvHERK1的植物表达载体(pK2GW7-VvHERK1)
CTAB法提取葡萄组培苗茎叶RNA，将500ng RNA用Plus All-in-one1st Strand cDNA Synthesis SuperMix(gDNAPurge)反转录试剂盒(购自诺唯赞生物科技股份有限公司)所提供的随机引物和反转录试剂进行反转录得到cDNA。然后通过Gateway技术构建pK2GW7-VvHERK1。操作按GatewayTM BPClonaseTMII Enzyme Mix和GatewayTM LRClonaseTMII Enzyme Mix试剂盒说明书进行。以上述cDNA为模板，用上下游引物：attB1：5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGATGGGTTGTGGGAAAAT-3′、attB2：5′-GGGGACCACTTTGTACAAGAAAGCTGGGTGCGTAATCTGGAACATCGTAT-3′进行PCR扩增得到VvHERK1蛋白的编码基因序列，该编码基因的核苷酸序列如序列表中序列2所示，该序列所编码的VvHERK1氨基酸序列如序列表中序列1所示。将经过两轮PCR扩增到带有attB接头的产物用DNA胶回收试剂盒(购自诺唯赞生物科技股份有限公司)进行目的片段胶回收，然后按照说明书进行BP反应，将BP反应后的连接产物转入大肠杆菌DH5α感受态细胞，后将菌液涂布于含有卡那霉素的LB平板上，用菌落PCR筛选阳性克隆，将其中1个阳性克隆送擎科公司测序。将测序正确的样品提质粒按照说明书方法进行LR反应，将LR反应后的连接产物转入大肠杆菌DH5α感受态细胞，后将菌液涂布于含有壮观霉素的LB平板上，用菌落PCR筛选阳性克隆，检测结果见图2(图2中泳道M为DNA分子量标准；泳道1、2、5、8、10为阳性克隆)。从图2可见，泳道1、2、5、8、10均有2490bp大小的片段，与预期结果一致。将其中1个阳性克隆进行测序和比对后证明该阳性克隆确实插入了VvHERK1基因序列，且阅读框正确，表明重组质粒构建正确。将该重组质粒命名为pK2GW7-VvHERK1(图1)。二、用冻融法分别将pK2GW7-VvHERK1、pK2GW7和GLRaV-2侵染性cDNA克隆质粒转化农杆菌GV3101。
将各装有30u1农杆菌GV3101感受态(唯地公司产品)的3个离心管(将其分别编号为1、2和3号)放在冰上，依次在1、2、3号离心管中加入量为1ug的pK2GW7、pK2GW7-VvHERK1和GLRaV-2侵染性克隆质粒(公众可从中国农业大学获得，记载过该载体的非专利文献是：(Zhang C，Wang X，Li H，et al.GLRaV-2p24protein suppresses host defenses byinteraction with a RAV transcription factor from grapevine.Plant Pathology，2022，189：1848-1865)，充分混匀。冰上放置5min、液氮快速冷却5min后迅速转入37℃水浴5min、放置冰上5min。然后在离心管中各加500ul无抗生素的YEP液体培养基后在28℃条件下用200r/min摇培养2-4h，吸取150ul菌液涂布到含相关抗生素的YEP固体培养基上，28℃恒温倒置培养48-60h。挑取单个、饱满菌落接种至800ul含相关抗生素的YEP液体培养基中，28℃200rpm摇床中摇菌12-16h。用菌落PCR筛选阳性克隆。取2ml阳性单克隆菌液，28℃180rpm摇培24h后，按照1∶100加菌液于三角瓶大摇过夜。用6000rpm转速离心5min收集菌液，将分别携带pK2GW7-VvHERK1和GLRaV-2侵染性克隆质粒的菌液沉淀用30m1农杆菌悬浮液(10mM MES，100mM MgCl2和10uMacetosyringone，MMA)重悬，使OD600达到1.0。用同样的方法得到含有pK2GW7和GLRaV-2侵染性克隆质粒的农杆菌悬浮液作为后面试验的对照。上述摇菌及集菌等过程均需无菌操作。
三、在无病毒葡萄愈伤组织中分别共转化pK2GW7-VvHERK1/GLRaV-2、pK2GW7/GLRaV-2。
将每份葡萄愈伤组织(10g)(公众可从中国农业大学获得，记载过该试验材料的非专利文献是：(Zhang C，Wang X，Li H，et al.GLRaV-2p24 protein suppresses hostdefenses by interaction with a RAV transcription factor from grapevine.PlantPathology，2022，189：1848-1865)放入30ml上述携带有两种质粒的农杆菌悬浮液中，常温条件下用100rpm摇30min。然后将液体愈伤组织用两层无菌纱布过滤农杆菌悬浮液后将其置于无菌滤纸上进一步吸干液体。最后将愈伤组织置于B5培养基上，在25℃暗培养3天。以上实验过程均需无菌操作。3天后分别提取愈伤组织的总RNA和总蛋白，-80℃保存备用。
四、在无病毒夏黑葡萄组培苗中用真空渗透法分别共转化pK2GW7-VvHERK1/GLRaV-2、pK2GW7/GLRaV-2。
在无菌广口瓶加入40ml上述携带有两种质粒的农杆菌悬浮液，将继代培养4周的夏黑葡萄组培苗浸没其中。将广口瓶放在玻璃真空干燥器中用-83kPa抽滤，20min后取出组培苗移入WPM固体培养基中培养。3天后提取组培苗细嫩茎叶的总RNA和总蛋白，-80℃保存备用。
五、Real-time qPCR检测GRLaV-2RNA积累水平。
分别将上述步骤三和四得到的总RNA用DNase I消解后，在紫外分光光度计上分别测定其在230nm、260nm和280nm的吸光值以确定其纯度和浓度。用试剂盒ChamQ SYBR qPCRMaster Mix(High ROX Premixed)(诺唯赞生物科技股份有限公司产品)进行Real-timeqPCR，检测葡萄Actin基因(VvActin，XM_002282480.4)的表达作为内参。以500ng总RNA作为模板，以试剂盒自带随机引物作为反向引物，进行RT反应。每个反应管依次加入0.5ul gDNAPurge和500ng总RNA，用RNase Free Water补足至5ul。42℃孵育5min，反应结束后冰上放置。向反应物中加入Plus 1st Strand cDNA SynthesisSuperMix。50℃孵育15min，75℃孵育5min，终止反应。反应产物-20℃保存。
每个PCR反应管中加入1.0ul用RNase Free Water稀释10倍的RT产物、5ul 2×ChamQ SYBR qPCR Master Mix、正反向引物各0.2ul、最后加3.6ul dd H2O补充至10ul。在ABI公司生产的荧光定量PCR-ABI7500扩增仪进行反应。反应条件是95℃，30s；95℃，10s；59℃，30s；40个循环。Real time PCR结束以后，根据扩增仪自带的软件对数据进行分析。
检测VvHERK1 mRNA的引物如下：
正向引物：5′-TGTTCAGTTCTTTCGATGGGTT-3′；
反向引物：5′-AGGATGAGTCAGATTTCGTGGC-3′。
检测GLRaV-2基因组RNA的引物如下：
正向引物：5′-GCTCAACCTCTCGTGCG-3′；
反向引物：5′-CGCTTCTCTCACTCCCAC-3′。
检测VvActin的mRNA的引物如下：
正向引物：5′-CCCCATGCTATCCTTCG-3′；
反向引物：5′-AGGCAGCTCATAGTTCTTCTC-3′。
实验结果见图3A和图4A，图中标注的VvHERK1和pK2GW7分别表示共转化pK2GW7-VvHERK1/GLRaV-2和pK2GW7/GLRaV-2。从图3A和图4A可见，与对照(共转化pK2GW7/GLRaV-2)相比，转入pK2GW7-VvHERK1/GLRaV-2的葡萄愈伤组织和组培苗中的VvHERK1 mRNA水平显著增加，而GLRaV-2基因组RNA水平显著下降，降幅为50％以上。这说明过表达VvHERK1能有效抑制GLRaV-2基因组复制。
六、Western blotting检测GRLaV-2蛋白积累水平。
将上述步骤三和步骤四得到的植物总蛋白进行Western blot检测GLRaV-2蛋白积累水平。GLRaV-2基因组第10个阅读框所编码的蛋白为24kDa蛋白(p24)，本实验用p24的抗血清检测p24来代表GLRaV-2蛋白积累水平。
将样品放入1.5ml离心管中加入200ul蛋白提取液，1ul蛋白酶抑制剂，混匀。4℃下12000g离心5min。取上清液并加入SDS-蛋白上样缓冲液(含DTT)，100℃煮沸5min。将变性后的样品放于冰上，分别制备分离胶和浓缩胶，凝30min后可用。缓慢上样，先用80V电泳20min、后用120V电泳1h。在滤纸上依次放置胶、PVDF膜和滤纸，然后用200mA电流低温转膜90min。转膜后用TBST漂洗膜3次，每次5min。用封闭液(5％脱脂奶粉)封闭60min。用TBST漂洗膜3次，每次5min。随后进行Western blot检测。先用一抗(p24抗血清1∶2000)孵育PVDF膜60min，用TBST漂洗膜3次。然后用羊抗兔二抗(康为公司产品)孵育PVDF膜60min，用TBST漂洗膜3次。将发光剂eECL-A和eECL-B(1∶1的混合物)均匀加到膜上，最后将膜放置到化学发光仪中曝光并拍照。
实验结果见图3B和图4B。图上方显示GLRaV-2的蛋白积累水平，下方为各泳道的上样量，用考马斯亮蓝染色。从图3B和图4B可见，与对照(共转化pK2GW7/GLRaV-2)相比，转入pK2GW7-VvHERK1/GLRaV-2的葡萄愈伤组织和组培苗中GLRaV-2蛋白积累水平显著下降，降幅约为50％。这再次说明过表达VvHERK1能有效抑制GLRaV-2基因组的复制。
本说明书中未作详细描述的内容属于本领域专业技术人员公知的现有技术。
Claims (3)
1.葡萄类受体蛋白激酶HERK1的新用途，其特征在于，所述葡萄类受体蛋白激酶HERK1可以抑制GLRaV-2基因组的复制，上述葡萄类受体蛋白激酶HERK1的序列如SEQ ID NO：1所示。
2.编码如权利要求1所述的葡萄类受体蛋白激酶HERK1的编码基因的应用，其特征在于：所述编码基因通过其编码的葡萄类受体蛋白激酶HERK1可以抑制GLRaV-2基因组的复制，上述编码基因的序列如SEQ ID NO：2所示。
3.含有如权利要求2所述的编码基因的重组表达载体的应用，其特征在于：所述重组表达载体上包含的编码基因通过其编码的葡萄类受体蛋白激酶HERK1可以抑制苹果茎沟病毒基因组的复制；
所述重组载体为在pK2GW7载体将ccdB序列替换为SEQ ID NO：2所示序列得到的重组表达载体。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311000390.8A CN117305267B (zh) | 2023-08-09 | 2023-08-09 | 葡萄类受体蛋白激酶herk1的新用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311000390.8A CN117305267B (zh) | 2023-08-09 | 2023-08-09 | 葡萄类受体蛋白激酶herk1的新用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117305267A true CN117305267A (zh) | 2023-12-29 |
| CN117305267B CN117305267B (zh) | 2024-05-28 |
Family
ID=89287290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311000390.8A Active CN117305267B (zh) | 2023-08-09 | 2023-08-09 | 葡萄类受体蛋白激酶herk1的新用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117305267B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101550420A (zh) * | 2008-11-25 | 2009-10-07 | 云南省烟草科学研究所 | 烟草受体类似蛋白激酶基因及其应用 |
| US20100333230A1 (en) * | 2008-01-31 | 2010-12-30 | State Of Oregon Acting By And Through The State Board Of Higher Educ. On Behalf Of Or State U. | Closterovirus vectors and methods |
| US20110138498A1 (en) * | 2009-12-07 | 2011-06-09 | Iowa State University Research Foundation, Inc. | Modulation of receptor-like kinases for promotion of plant growth |
| CN113403308A (zh) * | 2020-12-25 | 2021-09-17 | 华南农业大学 | 一种提高水稻抗白叶枯病的方法 |
| CN113416737A (zh) * | 2021-06-01 | 2021-09-21 | 河南科技大学 | 葡萄过氧化氢受体基因及其编码蛋白与应用 |
-
2023
- 2023-08-09 CN CN202311000390.8A patent/CN117305267B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100333230A1 (en) * | 2008-01-31 | 2010-12-30 | State Of Oregon Acting By And Through The State Board Of Higher Educ. On Behalf Of Or State U. | Closterovirus vectors and methods |
| CN101550420A (zh) * | 2008-11-25 | 2009-10-07 | 云南省烟草科学研究所 | 烟草受体类似蛋白激酶基因及其应用 |
| US20110138498A1 (en) * | 2009-12-07 | 2011-06-09 | Iowa State University Research Foundation, Inc. | Modulation of receptor-like kinases for promotion of plant growth |
| CN113403308A (zh) * | 2020-12-25 | 2021-09-17 | 华南农业大学 | 一种提高水稻抗白叶枯病的方法 |
| CN113416737A (zh) * | 2021-06-01 | 2021-09-21 | 河南科技大学 | 葡萄过氧化氢受体基因及其编码蛋白与应用 |
Non-Patent Citations (3)
| Title |
|---|
| "XP_034688269.1", 《NCBI REFERENCE SEQUENCE》, 2 June 2020 (2020-06-02) * |
| ZHANG C: "GLRaV-2p24protein suppresses host defenses by interaction with a RAV transcription factor from grapevine", 《PLANT PATHOLOGY》, vol. 3, no. 189, 29 April 2022 (2022-04-29), pages 1848 - 1865 * |
| 王萌;费菲;周涛;程玉琴;范在丰;: "葡萄卷叶伴随病毒2号和3号辽宁分离物部分基因组的序列分析", 植物病理学报, no. 05, 15 October 2009 (2009-10-15), pages 10 - 17 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117305267B (zh) | 2024-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peng et al. | Overexpressing a NPR1-like gene from Citrus paradisi enhanced Huanglongbing resistance in C. sinensis | |
| Bello et al. | Cloning of Gossypium hirsutum sucrose non-fermenting 1-related protein kinase 2 gene (GhSnRK2) and its overexpression in transgenic Arabidopsis escalates drought and low temperature tolerance | |
| CN106916825B (zh) | 番茄抗晚疫病基因SpNBS-LRR及其克隆方法与应用方法 | |
| Vinutha et al. | Tomato auxin biosynthesis/signaling is reprogrammed by the geminivirus to enhance its pathogenicity | |
| Geng et al. | Transcriptomic changes in Nicotiana benthamiana plants inoculated with the wild‐type or an attenuated mutant of Tobacco vein banding mosaic virus | |
| Li et al. | Blocking Osa‐miR1871 enhances rice resistance against Magnaporthe oryzae and yield | |
| US10150969B2 (en) | Methods and compositions to regulate plant transformation susceptibility | |
| Liu et al. | Analyses of MiRNA functions in maize using a newly developed ZMBJ-CMV-2bN81-STTM vector | |
| Jayasudha et al. | An efficient in-vitro Agrobacterium-mediated transformation protocol for raising salinity tolerant transgenic plants in fingermillet [Eleusine coracana (L.) Gaertn.]. | |
| WO2016065896A1 (zh) | OsAGO18蛋白或其编码基因在调控植物对水稻矮缩病毒或其同科病毒的抗性中的应用 | |
| Chen et al. | Dual resistance of transgenic plants against Cymbidium mosaic virus and Odontoglossum ringspot virus | |
| AU2014333405B2 (en) | A method for production of transgenic cotton plants | |
| CN104388463B (zh) | 黄瓜花叶病毒诱导的基因沉默系统及其应用 | |
| CN104561085A (zh) | OsAGO18基因在提高水稻对水稻条纹叶枯病抗性中的应用 | |
| WO2022121127A1 (zh) | 一种根结线虫病相关miRNA及其调控基因、蛋白和应用 | |
| Jiang et al. | Silencing P25, HC-Pro and Brp1 of potato virus (viroid) using artificial microRNA confers resistance to PVX, PVY and PSTVd in transgenic potato | |
| Reddy et al. | RETRACTED: Production of transgenic local rice cultivars (Oryza sativa L.) for improved drought tolerance using Agrobacterium mediated transformation | |
| WO2016128998A1 (en) | Improved transgenic rice plants | |
| Sundaresan et al. | Evaluating the strength of RNA silencing suppressor proteins encoded by two geminiviruses using assay based on reversal of GFP silencing | |
| CN117305267A (zh) | 葡萄类受体蛋白激酶herk1的新用途 | |
| US20190071685A1 (en) | Identification of crop myb transcription factors and their use | |
| CN113061623B (zh) | 一种表达病毒样颗粒的细胞核转化的转基因植物的制备方法及其在抵抗棉铃虫中的应用 | |
| CN114107327A (zh) | 绿色木霉高温胁迫响应关键酶基因TvHSP70、重组表达载体、工程菌及其应用 | |
| CN107083396B (zh) | ZmPDIL基因在玉米矮花叶病防治中的应用 | |
| CN107058375B (zh) | ZmPGK基因在玉米矮花叶病防治中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |